相关实验视频
Updated: Jul 20, 2025

09:48
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
399
微RNA向:用于卵巢癌的新型治疗干预措施
Elmira Roshani Asl1, Sajed Sarabandi2, Behrouz Shademan3
1Social Determinants of Health Research Center, Saveh University of Medical Sciences, Saveh, Iran.
Biochemistry and biophysics reports
|July 31, 2023
概括
这项研究探讨了microRNAs (miRNAs) 作为卵巢癌的关键参与者. 准这些分子为这种复杂疾病提供了有前途的诊断和治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 卵巢癌涉及复杂的细胞通信网络,驱动疾病的进展.
- 识别分子异常对于改善诊断和治疗至关重要.
- 微RNAs (miRNAs) 涉及各种细胞过程和疾病状态.
研究的目的:
- 为了确定卵巢癌中的关键分子异常.
- 研究微RNAs (miRNAs) 作为诊断生物标记物的作用.
- 在卵巢癌中探索基于miRNA的干预措施的治疗潜力.
主要方法:
- 文献综述专注于卵巢癌中的miRNA研究.
- 对调查卵巢癌患者miRNA表达特征的研究进行分析.
- 对miRNA向疗法的临床前和临床数据的检查.
主要成果:
- 微RNAs (miRNAs) 在卵巢癌中显著失调.
- 特定的miRNA显示出作为敏感和特定的诊断生物标记物的潜力.
- 向miRNAs可以调节多个致癌途径,提供治疗效益.
结论:
- 基于微RNA (miRNA) 的方法代表了卵巢癌诊断和治疗的前沿.
- 对特定miRNA角色和有针对性的传递系统进行进一步的研究是有必要的.
- 了解miRNA参与卵巢癌发病的过程,可以带来新的临床策略.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K

